Onconetix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0.06	0	0	0	0
Cost of Revenue	1.19	0	0	0	0
Gross Profit	-1.13	0	0	0	0
Selling, General & Admin	14.77	9.35	2.09	1.1	0.82
Research & Development	1.95	4.13	1.33	0.52	0.06
Other Operating Expenses	18.19	0	0	0	0
Operating Expenses	34.91	13.48	3.42	1.62	0.88
Operating Income	-36.03	-13.48	-3.42	-1.62	-0.88
Interest Expense / Income	0.67	0	0	0	0
Other Expense / Income	0.72	-0.06	-	-0.02	-0.06
Pretax Income	-37.42	-13.42	-3.42	-1.6	-0.82
Income Tax	-0.01	0	0	0	0
Net Income	-37.41	-13.42	-3.42	-1.6	-0.82
Preferred Dividends	0	0.1	0.63	0.56	0.28
Net Income Common	-37.41	-13.52	-4.04	-2.16	-1.1
Shares Outstanding (Basic)	17	12	3	3	3
Shares Outstanding (Diluted)	17	12	3	3	3
Shares Change	39.44%	283.48%	-	-	-
EPS (Basic)	-2.19	-1.10	-1.26	-0.67	-0.34
EPS (Diluted)	-2.19	-1.10	-1.26	-0.67	-0.34
Free Cash Flow	-13.64	-8.68	-2.05	-1.74	-0.83
Free Cash Flow Per Share	-0.80	-0.71	-0.64	-0.54	-0.26
Gross Margin	-1927.93%	-	-	-	-
Operating Margin	-61634.47%	-	-	-	-
Profit Margin	-63986.48%	-	-	-	-
Free Cash Flow Margin	-23323.46%	-	-	-	-
EBITDA	-36.71	-13.41	-3.41	-1.6	-0.82
EBITDA Margin	-62784.10%	-	-	-	-
Depreciation & Amortization	0.04	0.01	0	0	0
EBIT	-36.75	-13.42	-3.42	-1.6	-0.82
EBIT Margin	-62859.25%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).